NeuroAdvanced®

Advanced medical
care for mental health.

An AlmaraClinic protocol using ExoTMS® technology for Treatment-Resistant Depression, Obsessive-Compulsive Disorder (OCD), and other clinical conditions that require a structured, safe, and personalized medical approach.

NeuroAdvanced®

Advanced medical
care for mental health.

NeuroAdvanced®® is an AlmaraClinic clinical protocol with ExoTMS technology®, developed for mental health conditions that require medical assessment, precision and structured follow-up.

In conditions such as Treatment-Resistant Depression, Obsessive-Compulsive Disorder (OCD), and other clinical disorders, changes in brain circuits involved in mood, cognitive control, motivation, and repetitive behaviors may play a significant role.

NeuroAdvanced®® uses non-invasive neuromodulation within a physician-prescribed treatment plan, delivered under clinical supervision to help restore emotional balance, mental clarity, and quality of life.

Treatment-Resistant Depression OCD Emotional Regulation Cognitive control Motivation Mental Clarity
NeuroAdvanced com tecnologia ExoTMS na AlmaraClinic
NEUROADVANCED®
Clinical ExoTMS® protocol for medically indicated mental health conditions.

Backed by Clinical Evidence

Neuromodulation targets brain circuits involved in mental health.

Transcranial Magnetic Stimulation (TMS) uses magnetic fields to non-invasively modulate brain regions involved in emotional regulation, cognitive control, mood, anxiety, and compulsive behaviors.


2/3

of patients with Major Depressive Disorder or Treatment-Resistant Depression experience clinically significant improvement*

*

In patients with anxiety associated with depression, most experience a reduction in symptoms.*

1/3

of patients with Obsessive-Compulsive Disorder (OCD) achieve a clinically significant response.*

3/4

of patients with Binge Eating Disorder achieve clinically meaningful improvement.*

*The results presented are based on published clinical studies and international research on Transcranial Magnetic Stimulation (TMS). Individual treatment outcomes may vary depending on diagnosis, clinical profile, and the prescribed treatment plan.

CLINICAL INDICATIONS

Conditions where NeuroAdvanced®®
may be integrated.

NeuroAdvanced®® integrates physician-led Transcranial Magnetic Stimulation (TMS) protocols for a range of mental health conditions, always following a medical evaluation and the development of an individualized treatment plan.
Depressão resistente
01

Treatment-Resistant Depression

For patients who have not achieved the expected clinical response with conventional treatments.

Ansiedade
02

Anxiety

As part of a comprehensive treatment plan in selected cases, following medical evaluation.

Perturbação Obsessivo-Compulsiva
03

OCD

Targeted protocols focused on the brain circuits involved in obsessions and compulsions.

Burnout
04

Burnout

For emotional and physical exhaustion, integrated into a personalized treatment plan.

NEUROADVANCED® PATHWAY®

A clear, structured
and guided journey.

NeuroAdvanced® is determined following a medical assessment and psychiatric consultation, with a treatment plan tailored to the diagnosis, clinical history, symptoms, and therapeutic goals.
01

Medical Evaluation

Initial assessment of your overall health, medical history, current medications, and suitability for ExoTMS® treatment.

02

Psychiatric Consultation

A specialist psychiatric assessment to establish the diagnosis, evaluate symptoms and clinical history, and determine the appropriate treatment indication.

03

NeuroAdvanced® Treatment Plan®

Definition of the treatment protocol, stimulation target, number of sessions, and treatment frequency, always based on medical prescription.

04

ExoTMS® Sessions®

Non-invasive treatment sessions delivered under clinical supervision, with ongoing monitoring of your progress throughout the course of treatment.

01

More than 30 years of research.

Transcranial Magnetic Stimulation has been studied since the 1980s and continues to be one of the fastest-growing fields in neuromodulation research.

02

Thousands of published studies.

The safety and effectiveness of TMS are supported by thousands of peer-reviewed publications, clinical trials, and systematic reviews.

03

International clinical guidelines.

Recommended by leading international scientific organizations for treatment-resistant depression, obsessive-compulsive disorder (OCD), and other clinical indications.

04

No surgery. No anesthesia.

Treatment is performed on an outpatient basis, allowing patients to return to their normal daily activities immediately after each session.

WHAT MAKES IT DIFFERENT

Greater precision.
Less disruption to your daily life.

ExoTMS® is a non-invasive neuromodulation technology designed to deliver targeted stimulation in a comfortable way while fitting seamlessly into a personalized clinical treatment plan.
01

Non-Invasive

No surgery, no anesthesia, and no recovery time.

02

Fits Your Routine

Short treatment sessions with an immediate return to your normal daily activities.

03

Targeted Stimulation

Precisely targets brain regions involved in mood, anxiety, compulsive behaviors, and motivation.

04

Backed by Clinical Evidence

Supported by scientific research, regulatory approvals, and international clinical guidelines.

Single Session

ExoTMS®

20 min / session

200€ per session
PRIME PROTOCOL

NeuroAdvanced Prime®

20 min / session

Starting at 120€ per session

*The price shown corresponds to the per-session rate when included as part of a NeuroAdvanced® or NeuroAdvanced Prime® protocol. It includes 2 medical consultations and 1 psychiatric consultation, unless otherwise specified in the treatment plan proposed after clinical assessment. The NeuroAdvanced Prime® Protocol also includes 8 Clinical Psychology consultations.

Book Your Assessment

Take the first step
a personalized clinical treatment plan.

Complete your details and our team will contact you to schedule your NeuroCheck®—your first visit to the clinic and the starting point for your personalized clinical assessment.